Paul M. Van Bergen En Henegouwen

Utrecht, UT 3584CG, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Generation of a perfusable three-dimensional human neurovascular chip to model brain drug delivery and immune cell extravasation.

Generation of a perfusable three-dimensional human neurovascular chip to model brain drug delivery and immune cell extravasation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 04, 2025

Author Correction: Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Author Correction: Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Journal: Scientific reports

Published: April 28, 2025

Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models.

Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 12, 2024

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 17, 2024

Erratum: Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum.

Erratum: Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum.

Journal: Theranostics

Published: January 22, 2024

Structural insights into the role and targeting of EGFRvIII.

Structural insights into the role and targeting of EGFRvIII.

Journal: Structure (London, England : 1993)

Published: November 03, 2023

A Nanobody-on-Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR).

A Nanobody-on-Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR).

Journal: Angewandte Chemie (International ed. in English)

Published: May 27, 2022

Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.

Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 03, 2022

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Journal: Scientific reports

Published: February 03, 2022

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.

Journal: Molecular pharmaceutics

Published: January 19, 2022

Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody.

Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody.

Journal: BMC molecular and cell biology

Published: October 08, 2021

Multifaceted Activities of Seven Nanobodies against Complement C4b.

Multifaceted Activities of Seven Nanobodies against Complement C4b.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 01, 2021

Showing 1-12 of 71

Last Updated: 09/26/2026